US Edition‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warning
- The FDA issued warning letters in early 2025 to companies distributing unlawful tianeptine products linked to severe adverse effects across the U.S.
- This followed a surge in poison control center calls reporting tianeptine exposures, increasing 525% from 2018 to 2023, and widespread product contamination issues.
- Products containing tianeptine, often sold as energy shots or supplements at gas stations, are nicknamed 'gas station heroin' due to opioid-like effects and risks of seizures and death.
- The FDA warned that about 20% of bioreactor runs used in tianeptine production were rejected for contamination, and firms failed to complete investigations or justify corrective actions.
- Eight states banned tianeptine, but ongoing recalls and import alerts imply broader efforts are needed to address this unapproved, addictive drug's public health risks.
17 Articles
17 Articles
Daily Journal
‘Gas Station Heroin’ Spurs Spike in Poison Control Calls, FDA Warning
Key Takeaways
'Gas station heroin' tied to spike in poisonings, health officials warn - Political Signal
Health officials are warning Americans about the dangers of tianeptine, a drug often sold in gas stations and smoke shops under names like “Zaza,” “Tianaa” and “Neptune’s Fix.” Marketed as energy boosters or mood enhancers, experts say these products contain an unapproved antidepressant that mimics some effects of opioids, and can be addictive. Tianeptine is […] The post ‘Gas station heroin’ tied to spike in poisonings, health officials warn app…
FDA warns seafood processors in France and Nicaragua about HACCP violations
As part of its enforcement activities, the Food and Drug Administration sends warning letters to entities under its jurisdiction. Some letters are not posted for public view until weeks or months after they are sent. Business owners have 15 days to respond to FDA warning letters. Warning letters often are not issued until a company has been given months to years to correct problems. Reunipeche SAS Le Port, La Reunion, France The FDA issued a war…
Coverage Details
Bias Distribution
- 50% of the sources are Center
To view factuality data please Upgrade to Premium
